Trials / Recruiting
RecruitingNCT07237516
Zymfentra (Infliximab-dyyb) REal World Cohort STudy
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 200 (estimated)
- Sponsor
- University of North Carolina, Chapel Hill · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this observational study is to learn about how effective Zymfentra (IFX=dyyb) is when treating patients with Crohn's disease (CD) and ulcerative colitis (UC) Does Zymfentra lead to a reduction in symptoms at intervals throughout one year? Participants being prescribed Zymfentra (IFX-dyyb as part of their regular medical care for CD or UC will answer online survey questions about their bowel habits for 1 year.
Conditions
Timeline
- Start date
- 2025-11-20
- Primary completion
- 2028-11-03
- Completion
- 2028-11-03
- First posted
- 2025-11-19
- Last updated
- 2026-03-17
Locations
5 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT07237516. Inclusion in this directory is not an endorsement.